{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"submitter":["Yang J"],"funding":["National Key Research and Development Program of China"],"pagination":["1061814"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC9807785"],"repository":["biostudies-literature"],"omics_type":["Unknown"],"volume":["13"],"pubmed_abstract":["<h4>Introduction</h4>Gangliosides play an essential role in cancer development and progression. However, the involvement of gangliosides in the prognosis and tumor microenvironment (TME) of neuroblastoma is not entirely understood.<h4>Methods</h4>Consensus clustering analysis was performed to identify ganglioside-mediated molecular subtypes. LASSO-Cox analysis was conducted to identify independent prognostic genes, and a novel risk signature was constructed. The risk signature was validated internally and externally. We further explored the independent prognosis value, immune landscape, drug susceptibility, and tumor dedifferentiation of the risk signature. The role of the signature gene B3GALT4 in neuroblastoma was explored <i>in vitro</i>.<h4>Results</h4>Seventeen ganglioside-related gen"],"journal":["Frontiers in immunology"],"pubmed_title":["A novel ganglioside-related risk signature can reveal the distinct immune landscape of neuroblastoma and predict the immunotherapeutic response."],"pmcid":["PMC9807785"],"funding_grant_id":["2018YFC1313000, 2018YFC1313001"],"pubmed_authors":["Liu Y","Yang J","Li Z","Li J","Gong B","Han L","Zhao Q","Sha Y","Jin Y","Wang Y"],"additional_accession":[]},"is_claimable":false,"name":"A novel ganglioside-related risk signature can reveal the distinct immune landscape of neuroblastoma and predict the immunotherapeutic response.","description":"<h4>Introduction</h4>Gangliosides play an essential role in cancer development and progression. However, the involvement of gangliosides in the prognosis and tumor microenvironment (TME) of neuroblastoma is not entirely understood.<h4>Methods</h4>Consensus clustering analysis was performed to identify ganglioside-mediated molecular subtypes. LASSO-Cox analysis was conducted to identify independent prognostic genes, and a novel risk signature was constructed. The risk signature was validated internally and externally. We further explored the independent prognosis value, immune landscape, drug susceptibility, and tumor dedifferentiation of the risk signature. The role of the signature gene B3GALT4 in neuroblastoma was explored <i>in vitro</i>.<h4>Results</h4>Seventeen ganglioside-related gen","dates":{"release":"2022-01-01T00:00:00Z","publication":"2022","modification":"2026-05-10T03:07:15.25Z","creation":"2024-12-04T03:34:53.674Z"},"accession":"S-EPMC9807785","cross_references":{"pubmed":["36605200"],"doi":["10.3389/fimmu.2022.1061814"]}}